✦ LIBER ✦

9236 Results of PX-171–003-A0, part 1 of an open-label, single-arm, phase 2 study of carfilzomib in patients with relapsed and refractory multiple myeloma

✍ Scribed by Siegel, D.; Vij, R.; Stewart, K.; Somlo, G.; Jakubowiak, A.; Kukreti, V.; Bahlis, N.; Singhal, S.; Wong, A.; Jagannath, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Open-Label Single-Arm Pilot Phase II

✍ Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, An 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 400 KB

A377 Phase II Study of Carfilzomib in Pa

✍ Jagannath, S; Vij, R; Stewart, AK; Somlo, G; Jakubowiak, A; Reiman, T; Trudel, S 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 85 KB

An open-label, single-arm, phase 2 study

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Design and rationale of FOCUS (PX-171-01

✍ Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 167 KB

Tanespimycin and bortezomib combination

✍ Paul G. Richardson; Asher A. Chanan-Khan; Sagar Lonial; Amrita Y. Krishnan; Mich 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Thalidomide for Patients With Relapsed M

✍ Richardson, Paul; Schlossman, Robert; Jagannath, Sundar; Alsina, Melissa; Desika 📂 Article 📅 2004 🏛 Mayo Clinic 🌐 English ⚖ 147 KB